Fundz

Apitoria Pharma acquires A1 Biochem Group's services

PRIVATEOct 05, 2026

Acquiring Company

Apitoria Pharma

Acquired Company

A1 Biochem Group

United StatesBiotechnologyHealth CarePharmaceuticalBiotechnology

Description

Apitoria Pharma, a subsidiary of Aurobindo Pharma, is acquiring the Contract Research Services business of A1 Biochem Group. The transaction includes A1 Biochem USA acquiring 100% of A1 Biochem Labs LLC. This move allows A1 Biochem Labs LLC to become a step-down subsidiary of A1 Biochem Labs India. The acquisition is based on definitive agreements signed for this purpose.

Company Information

Company

Apitoria Pharma

About

Apitoria Pharma is a subsidiary of Aurobindo Pharma. It focuses on providing innovative and high-quality pharmaceutical services. The company is engaged in various phases of drug development and research. Apitoria aims to enhance drug delivery solutions and patient outcomes.

Fundz sees it the moment Apitoria Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Apitoria Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired A1 Biochem Group?

A1 Biochem Group was acquired by Apitoria Pharma. The deal was reported on October 5, 2026. Apitoria Pharma is a subsidiary of Aurobindo Pharma. It focuses on providing innovative and high-quality pharmaceutical services. The company is engaged in various phases of drug development and research. Apitoria Pharma is privately held and operates in Biotechnology.

When did Apitoria Pharma acquire A1 Biochem Group?

Apitoria Pharma's acquisition of A1 Biochem Group was reported on October 5, 2026. Apitoria Pharma, a subsidiary of Aurobindo Pharma, is acquiring the Contract Research Services business of A1 Biochem Group. The transaction includes A1 Biochem USA acquiring 100% of A1 Biochem Labs LLC. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does A1 Biochem Group do?

A1 Biochem Group specializes in biochemistry and contract research services. The company offers various biological and chemical research services. A1 Biochem is recognized for its development support in the pharmaceutical sector. It is privately held, operating in Biotechnology, and is based in United States.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.